Further, the mutation types of PCK2 in HCC were assessed in the cBioPortal database, and samples from three databases were obtained, among which the mutations of PCK2 in HCC were primarily missense mutations (Fig. 4E). This evidence concerns the gene PCK2 and hepatocellular carcinoma.